These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16254334)

  • 1. Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines.
    Hong GK; Kumar P; Wang L; Damania B; Gulley ML; Delecluse HJ; Polverini PJ; Kenney SC
    J Virol; 2005 Nov; 79(22):13984-92. PubMed ID: 16254334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease.
    Jones RJ; Seaman WT; Feng WH; Barlow E; Dickerson S; Delecluse HJ; Kenney SC
    Int J Cancer; 2007 Sep; 121(6):1274-81. PubMed ID: 17520680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.
    Hong GK; Gulley ML; Feng WH; Delecluse HJ; Holley-Guthrie E; Kenney SC
    J Virol; 2005 Nov; 79(22):13993-4003. PubMed ID: 16254335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.
    Ma SD; Hegde S; Young KH; Sullivan R; Rajesh D; Zhou Y; Jankowska-Gan E; Burlingham WJ; Sun X; Gulley ML; Tang W; Gumperz JE; Kenney SC
    J Virol; 2011 Jan; 85(1):165-77. PubMed ID: 20980506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of inflammatory cytokines by Epstein-Barr virus (EBV)-infected lymphoblastoid cell lines spontaneously originated from the peripheral blood of patients with human immunodeficiency virus (HIV) infection.
    Roncella S; Baldi L; Cutrona G; Viale M; Rizzo F; Gasco M; Ferrarini M; Pistoia V
    Clin Immunol Immunopathol; 1995 Nov; 77(2):162-71. PubMed ID: 7586723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation of the role of Epstein-Barr virus immediate-early protein BZLF1 in B-cell transformation.
    Katsumura KR; Maruo S; Wu Y; Kanda T; Takada K
    J Gen Virol; 2009 Oct; 90(Pt 10):2331-2341. PubMed ID: 19553389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.
    Bristol JA; Brand J; Ohashi M; Eichelberg MR; Casco A; Nelson SE; Hayes M; Romero-Masters JC; Baiu DC; Gumperz JE; Johannsen EC; Dinh HQ; Kenney SC
    PLoS Pathog; 2022 Apr; 18(4):e1010453. PubMed ID: 35472072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
    Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
    J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
    Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
    J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.
    Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH
    J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL; Kenney SC
    Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human B-lymphoid cell lines.
    Nilsson K
    Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model of angiogenesis in mice with severe combined immunodeficiency (SCID) and xenoengrafted with Epstein-Barr virus-transformed B cells.
    Woodford NL; Call DR; Remick DG; Rochford R
    Comp Med; 2004 Apr; 54(2):209-15. PubMed ID: 15134368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.